LFCR Q2 2022 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$256M

Q2 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$43M-66.8% YoY

Gross Profit

$15M33.9% margin

Operating Income

$4M9.5% margin

Net Income

-$38M-88.5% margin

EPS (Diluted)

$-1.30

QoQ Revenue Growth

+4.4%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$10M

Stock-Based Comp.

$686,000

Balance Sheet

Total Assets

$422M

Total Liabilities

$266M

Stockholders' Equity

$156M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$131M	-66.8%
Gross Profit	$15M	$21M	-28.7%
Operating Income	$4M	-$1M	+382.4%
Net Income	-$38M	-$13M	-189.0%